Ocay, Emma C.
HRN: 21-21-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/23/2025
03/30/2025
IVTT
1.5gr
Q8
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes